Corrigendum to "Phase IB trial of high dose ascorbic acid + nab-paclitaxel + cisplatin + gemcitabine in patients with untreated metastatic pancreatic cancer" [Redox Biol. 88 (2025) 103895].

Authors

Gayle S Jameson, S Danielle LeGrand, Michael S Gordon, Denise J Roe, Betsy C Wertheim, Kellen Olszewski, Josh Rabinowitz, Ron Evans, Michael Downes, Morgan Truitt, Ron Korn, Haiyong Han, Richard M Miller, Michael T Barrett, David Propper, Daniel D Von Hoff, Erkut Borazanci

Published in

Redox biology. Pages 104395. Oct 16, 2026. Epub Oct 16, 2026.

PMID:
42888162
Bibliographic data and abstract were imported from PubMed on 17 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.